BioNTech SE BNTX Ratios (2018-2026)

NASDAQ BNTX
$103.76 +0.88 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

BioNTech SE Quarterly Ratios

Periods 32 quarters
Latest Jun 2026

BioNTech SE reported a gross margin of 8.14% and a net margin of -849.05% for the quarter ended Jun 2026. These financial ratios cover 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
99.57%89.46%79.70%76.08%78.25%95.71%92.48%2.86%81.93%87.89%68.50%53.54%85.63%79.54%54.16%70.71%90.24%63.27%39.54%8.14%
EBT Margin
76.67%85.20%78.72%72.56%70.61%74.16%55.42%-245.80%25.40%44.84%-176.87%-626.11%12.75%25.31%-243.65%-154.41%1.63%-25.06%-481.03%-813.16%
EBIT Margin
77.60%84.95%74.56%69.13%68.98%76.97%51.25%-335.90%8.16%35.58%-270.36%-750.74%0.84%12.49%-292.18%-192.14%-3.09%-35.57%-573.67%-897.82%
EBITDA Margin
77.60%84.95%74.56%69.13%68.98%76.97%51.25%-335.90%8.16%35.58%-270.36%-750.74%0.84%12.49%-292.18%-192.14%-3.09%-35.57%-573.67%-897.82%
Operating Margin
77.60%84.95%74.56%69.13%68.98%76.97%51.25%-335.90%8.16%35.58%-270.36%-750.74%0.84%12.49%-292.18%-192.14%-3.09%-35.57%-573.67%-897.82%
Net Margin
100.60%57.23%99.42%92.81%0.31%95.05%-0.03%4.89%-0.96%58.72%11.89%-83.61%9.58%28.82%-235.67%-160.58%5.14%-16.51%-418.80%-849.05%
FCF Margin
26.10%4.32%64.23%124.81%140.32%22.57%-49.51%2,655.87%96.55%63.20%-137.95%1,333.18%-45.48%-33.34%-400.33%66.56%53.76%41.07%-308.38%61.65%
Efficiency
Inventory AverageInventory Avg.
0.42B0.52B0.55B0.45B0.34B0.37B0.45B0.47B0.47B0.42B0.38B0.37B0.35B0.32B0.29B0.26B0.26B0.20B0.13B0.12B
Assets AverageAssets Avg.
13.90B17.45B20.45B22.68B22.71B23.30B23.72B23.95B24.19B24.46B24.47B24.06B24.27B24.34B23.18B23.39B24.72B25.27B25.13B24.16B
Invested CapitalInvested Cap.
12.37B13.82B18.04B18.19B18.76B20.49B21.77B21.70B21.68B21.85B21.75B20.67B21.14B22.59B20.21B21.25B21.86B22.65B22.13B20.87B
Asset Utilization RatioAsset Util.
1.181.281.321.060.900.790.530.390.280.170.120.120.140.120.130.130.140.130.130.13
Leverage & Solvency
Interest Coverage RatioInterest Cover
-57.12-0.00B-709.36-380.97-555.23-20.70-22.57433.31-36.55-20.88107.91132.36-1.31-11.7915.7671.591.8676.8660.49120.01
Debt Ratio
0.120.010.010.010.010.000.000.000.000.000.000.010.010.080.010.010.010.010.010.01
Times Interest Earned
-57.12-0.00B-709.36-380.97-555.23-20.70-22.57433.31-36.55-20.88107.91132.36-1.31-11.7915.7671.591.8676.8660.49120.01
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
-3.06-0.02
FCF Payout RatioFCF Cover
-0.24-0.10
Dividend YieldDiv. Yield
-2.81%-1.47%
Payout Ratio
-0.33-44.43
Valuation
Price to EarningsP/E
8.9017.575.9211.620.00B8.73-0.00B0.00B-0.00B26.85905.24-164.87215.5074.63-48.22-53.89259.20-138.06-38.82-22.58
Price to SalesP/S
8.9510.055.8810.799.548.2921.90142.4426.8615.77107.61137.8420.6521.50113.6486.5513.3322.79162.56191.70
Price to BookP/B
6.264.682.362.051.801.771.381.201.211.151.010.931.351.321.101.221.101.081.031.14
Enterprise Value
61.45B61.71B35.12B26.78B19.70B22.09B17.72B13.48B15.53B20.21B17.50B15.84B28.98B7.85B13.78B18.65B8.97B12.17B8.17B9.88B
EV to EBIT
11.0311.486.5811.368.186.5825.22-21.98195.1535.70-31.75-15.220.00B49.41-24.52-32.89-163.64-32.38-10.30-8.96
EV to EBITDA
11.0311.486.5811.368.186.5825.22-21.98195.1535.70-31.75-15.220.00B49.41-24.52-32.89-163.64-32.38-10.30-8.96
Market Capitalization
64.27B63.63B42.10B36.80B33.29B36.20B30.02B26.01B26.18B25.09B21.93B19.10B28.23B27.34B21.85B25.55B23.67B24.07B22.48B23.53B
Price to FCFP/FCF
34.30232.819.168.646.8036.74-44.245.3627.8224.95-78.0010.34-45.42-64.51-28.39130.0224.7955.49-52.71310.97
EV to FCF
32.79225.817.646.294.0222.42-26.112.7816.5020.10-62.238.57-46.61-18.51-17.9094.939.4028.04-19.16130.52
EV to CFO
34.72270.417.736.404.0926.12-24.372.8217.5922.07-50.769.04-41.30-15.85-16.78112.499.8333.77-16.58809.23
Return Ratios
Return on Sales [ROS]ROS
77.60%84.95%74.56%69.13%68.98%76.97%51.25%-335.90%8.16%35.58%-270.36%-750.74%0.84%12.49%-292.18%-192.14%-3.09%-35.57%-573.67%-897.82%
Return on Capital Employed [ROCE]ROCE
159.16%103.96%132.36%100.79%82.67%58.71%37.75%24.87%14.80%3.04%-2.14%-4.00%-4.32%-6.57%-6.21%-4.13%-4.19%-6.21%-7.18%-9.74%
Return on Invested Capital [ROIC]ROIC
160.82%180.93%174.39%133.55%107.94%87.20%53.41%33.91%20.40%4.10%-2.91%0.18%-2.55%-6.63%-6.91%-5.14%-4.28%-6.38%-7.46%-10.44%
Return on Assets [ROA]ROA
116.60%133.65%136.11%108.75%90.57%75.35%48.15%31.60%19.67%6.31%0.76%0.04%-0.74%-3.07%-3.74%-2.04%-2.09%-4.18%-5.03%-7.59%